Microfluidics Market Is Ready to Observe Highest Revenue Growth up to US$ 12,927.6 Mn by 2027 | Coherent Market Insights
Microfluidics Market |
The increasing demand for
point-of-care (POC) diagnostics, rising frequency of persistent diseases,
shorter turnaround times for analyses, and advancements in device portability
are driving the growth of the global Microfluidics
Market. Point-of-care testing enables medical personnel to diagnose
patients in a hospital, field, ambulance, doctor's office, or at home. Due to
their need for small sample volumes and usage of micro-fabricated channels for
sample analysis, devices aided by microfluidic technology are being used for
point-of-care testing. POC testing equipment is already widely utilised in the
blood, HIV, glucose, and haemoglobin testing industries. Future POC testing
devices might have a strong emphasis on cancer and antibiotic treatments.
Due to the large number of people
affected by these diseases in both developed and developing countries, POC
testing devices based on microfluidic technology have enormous promise. The
clinical diagnostics sector is anticipated to increase at a significant rate during
the projected period of time and is estimated to have the largest global Microfluidics
Market share.
Clinical diagnostics is a significant area of use for microfluidics. A variety
of biochemical analysis procedures can be used to identify diseases, such as
toxicity, and they can also be detected by observing symptoms. Before visible
damage to microscopic cells or other types of symptoms, changes in the patients'
blood can indicate organ dysfunction or damage.
The Global Microfluidics Market Is Estimated To Account For US$ 3,800.4
Mn In Terms Of Value In 2018 And Is Expected To Reach US$ 12,927.6 Mn By The
End Of 2027.
With the use of plastic
microfluidic chips that are fully integrated, have the ability to identify or
sample a patient, and that too with no or minimal invasion, there has been an
increase in the demand for the development of an affordable and
simple-to-handle biochip for clinical diagnostics. Therefore, it is anticipated
that the development of clinical diagnostics would contribute to the growth of
the worldwide Microfluidics Market.
The greatest Microfluidics Market share currently belongs to the North American
area, and it is anticipated that this dominance will last during the projected
period. This is attributed to a number of causes, including improved
reimbursement regulations, an established healthcare system, and a higher
percentage of advanced therapy adoption by the populace. With regard to
significant budget cuts for research and development, microfluidics is
expanding at an explosive rate, particularly in the U.S. Microfluidic
techniques are primarily used in point-of-care and molecular diagnostics, which
have a significant market share in the United States. As a result, the United
States controls a large portion of the market in North America.
Top Manufacturers are- Agilent Technologies, PerkinElmer Inc.,
Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad Laboratories, Inc., Fluidigm
Corporation, Abbott Laboratories, and F. Hoffmann-La Roche Ltd.
Read the Press Release of Microfluidics
Market
Comments
Post a Comment